Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Sexually Transmitted Diseases

  Free Subscription

Articles published in J Virol

Retrieve available abstracts of 44 articles:
HTML format

Single Articles

    February 2024
  1. KHALIL MI, Yang C, Vu L, Chadha S, et al
    The membrane-associated ubiquitin ligase MARCHF8 stabilizes the human papillomavirus oncoprotein E7 by degrading CUL1 and UBE2L3 in head and neck cancer.
    J Virol. 2024;98:e0172623.
    PubMed     Abstract available

    October 2023
  2. PRABHAKAR AT, James CD, Fontan CT, Otoa R, et al
    Direct interaction with the BRD4 carboxyl-terminal motif (CTM) and TopBP1 is required for human papillomavirus 16 E2 association with mitotic chromatin and plasmid segregation function.
    J Virol. 2023;97:e0078223.
    PubMed     Abstract available

    September 2023
  3. BOURNE N, Keith CA, Miller AL, Pyles RB, et al
    Boosting of vaginal HSV-2-specific B and T cell responses by intravaginal therapeutic immunization results in diminished recurrent HSV-2 disease.
    J Virol. 2023;97:e0066923.
    PubMed     Abstract available

    August 2023
  4. MORI S, Ishii Y, Takeuchi T, Kukimoto I, et al
    Nuclear proinflammatory cytokine S100A9 enhances expression of human papillomavirus oncogenes via transcription factor TEAD1.
    J Virol. 2023;97:e0081523.
    PubMed     Abstract available

    June 2023
  5. ZWOLINSKA K, Bienkowska-Haba M, Scott RS, Keiffer T, et al
    Experimental Support for Human Papillomavirus Genome Amplification Early after Infectious Delivery.
    J Virol. 2023;97:e0021423.
    PubMed     Abstract available

  6. LOTOTSKAJA E, Liblekas L, Piirsoo M, Laanevali A, et al
    Phosphorylation of E2 Serine Residue 402 Is Required for the Transcription and Replication of the HPV5 Genome.
    J Virol. 2023;97:e0064323.
    PubMed     Abstract available

    May 2023
  7. ISHII Y, Yamaji T, Sekizuka T, Homma Y, et al
    Folliculin Prevents Lysosomal Degradation of Human Papillomavirus To Support Infectious Cell Entry.
    J Virol. 2023;97:e0005623.
    PubMed     Abstract available

    March 2023
  8. PRABHAKAR AT, James CD, Fontan CT, Otoa R, et al
    Human Papillomavirus 16 E2 Interaction with TopBP1 Is Required for E2 and Viral Genome Stability during the Viral Life Cycle.
    J Virol. 2023;97:e0006323.
    PubMed     Abstract available

  9. CHEN J, Wang D, Wang Z, Wu K, et al
    Critical Residues Involved in the Coassembly of L1 and L2 Capsid Proteins of Human Papillomavirus 16.
    J Virol. 2023;97:e0181922.
    PubMed     Abstract available

    February 2023
  10. BIENKOWSKA-HABA M, Zwolinska K, Keiffer T, Scott RS, et al
    Human Papillomavirus Genome Copy Number Is Maintained by S-Phase Amplification, Genome Loss to the Cytosol during Mitosis, and Degradation in G(1) Phase.
    J Virol. 2023;97:e0187922.
    PubMed     Abstract available

    January 2023
  11. LI S, Yim MK, Yip KL, Xiao C, et al
    E6-Encoded by Cancer-Causing Human Papillomavirus Interacts with Aurora Kinase A To Promote HPV-Mediated Carcinogenesis.
    J Virol. 2023 Jan 30:e0187222. doi: 10.1128/jvi.01872.
    PubMed     Abstract available

    December 2022
  12. REHM TM, Straub E, Forchhammer S, Leiter U, et al
    Transcription Properties of Beta-HPV8 and HPV38 Genomes in Human Keratinocytes.
    J Virol. 2022;96:e0149822.
    PubMed     Abstract available

    November 2022
  13. CASTAGNINO P, Kim HW, Lam LKM, Basu D, et al
    Systematic Analysis of IL-1 Cytokine Signaling Suppression by HPV16 Oncoproteins.
    J Virol. 2022;96:e0132622.
    PubMed     Abstract available

  14. JOSE L, Androphy EJ, DeSmet M
    SETD6 Regulates E2-Dependent Human Papillomavirus Transcription.
    J Virol. 2022;96:e0129522.
    PubMed     Abstract available

  15. BRONIARCZYK JK, Massimi P, Trejo-Cerro O, Myers MP, et al
    HPV-18E6 Inhibits Interactions between TANC2 and SNX27 in a PBM-Dependent Manner and Promotes Increased Cell Proliferation.
    J Virol. 2022 Nov 3:e0136522. doi: 10.1128/jvi.01365.
    PubMed     Abstract available

    October 2022
  16. DACUS D, Stancic S, Pollina SR, Rifrogiate E, et al
    Beta Human Papillomavirus 8 E6 Induces Micronucleus Formation and Promotes Chromothripsis.
    J Virol. 2022;96:e0101522.
    PubMed     Abstract available

  17. TREJO-CERRO O, Massimi P, Broniarczyk J, Myers M, et al
    Repression of Memo1, a Novel Target of Human Papillomavirus Type 16 E7, Increases Cell Proliferation in Cervical Cancer Cells.
    J Virol. 2022 Oct 5:e0122922. doi: 10.1128/jvi.01229.
    PubMed     Abstract available

    September 2022
  18. WANG W, Xi Y, Li S, Liu X, et al
    Restricted Recruitment of NK Cells with Impaired Function Is Caused by HPV-Driven Immunosuppressive Microenvironment of Papillomas in Aggressive Juvenile-Onset Recurrent Respiratory Papillomatosis Patients.
    J Virol. 2022 Sep 26:e0094622. doi: 10.1128/jvi.00946.
    PubMed     Abstract available

    August 2022
  19. PRABHAKAR AT, James CD, Das D, Fontan CT, et al
    Interaction with TopBP1 Is Required for Human Papillomavirus 16 E2 Plasmid Segregation/Retention Function during Mitosis.
    J Virol. 2022;96:e0083022.
    PubMed     Abstract available

  20. VATS A, Trejo-Cerro O, Massimi P, Banks L, et al
    Regulation of HPV E7 Stability by E6-Associated Protein (E6AP).
    J Virol. 2022 Aug 2:e0066322. doi: 10.1128/jvi.00663.
    PubMed     Abstract available

    June 2022
  21. OLCZAK P, Matsui K, Wong M, Alvarez J, et al
    RG2-VLP: a Vaccine Designed to Broadly Protect against Anogenital and Skin Human Papillomaviruses Causing Human Cancer.
    J Virol. 2022 Jun 15:e0056622. doi: 10.1128/jvi.00566.
    PubMed     Abstract available

    May 2022
  22. POIRSON J, Suarez IP, Straub ML, Cousido-Siah A, et al
    High-Risk Mucosal Human Papillomavirus 16 (HPV16) E6 Protein and Cutaneous HPV5 and HPV8 E6 Proteins Employ Distinct Strategies To Interfere with Interferon Regulatory Factor 3-Mediated Beta Interferon Expression.
    J Virol. 2022;96:e0187521.
    PubMed     Abstract available

    April 2022
  23. FONS NR, Kines RC, Thompson CD, Day PM, et al
    Chondroitin Sulfate Proteoglycans Are De Facto Cellular Receptors for Human Papillomavirus 16 under High Serum Conditions.
    J Virol. 2022;96:e0185721.
    PubMed     Abstract available

    January 2022
  24. WU X, Xiao Y, Zhou S, Wang Y, et al
    Transcriptomic Landscape of Gene Expression Profiles and Pathways in Juvenile-Onset Recurrent Respiratory Papillomatosis Tumor Tissues and Human Papillomavirus 6 and 11 E6- and E7-Overexpressing Head and Neck Squamous Cell Carcinoma Cell Lines.
    J Virol. 2022;96:e0134221.
    PubMed     Abstract available

  25. VATS A, Skrabar N, Del Sal G, Banks L, et al
    Loss of the E6AP ubiquitin ligase induces p53-dependent phosphorylation of HPV-18 E6 in cells derived from cervical cancer.
    J Virol. 2022 Jan 19:JVI0150321. doi: 10.1128/JVI.01503.
    PubMed     Abstract available

    December 2021
  26. MARTINEZ-NOEL G, Szajner P, Kramer RE, Boyland KA, et al
    Identification of microRNAs that stabilize p53 in HPV-positive cancer cells.
    J Virol. 2021 Dec 8:JVI0186521. doi: 10.1128/JVI.01865.
    PubMed     Abstract available

    September 2021
  27. COURSEY TL, Van Doorslaer K, McBride AA
    Regulation of Human Papillomavirus 18 Genome Replication, Establishment, and Persistence by Sequences in the Viral Upstream Regulatory Region.
    J Virol. 2021;95:e0068621.
    PubMed     Abstract available

    April 2021
  28. LOTOTSKAJA E, Sahharov O, Piirsoo M, Kala M, et al
    Cyclic AMP-dependent protein kinase exhibits antagonistic effects on the replication efficiency of different HPV types.
    J Virol. 2021 Apr 14. pii: JVI.00251-21. doi: 10.1128/JVI.00251.
    PubMed     Abstract available

    January 2021
  29. PIM D, Broniarczyk J, Siddiqa A, Massimi P, et al
    Human Papillomavirus 16 L2 Recruits both Retromer and Retriever Complexes during Retrograde Trafficking of the Viral Genome to the Cell Nucleus.
    J Virol. 2021;95.
    PubMed     Abstract available

    December 2020
  30. CONRADY MC, Suarez I, Gogl G, Frecot DI, et al
    Structure of High-Risk Papillomavirus 31 E6 Oncogenic Protein and Characterization of E6/E6AP/p53 Complex Formation.
    J Virol. 2020;95.
    PubMed     Abstract available

    October 2020
  31. STINN T, Kuntz S, Varon D, Huang ML, et al
    Subclinical genital herpes shedding in HIV/HSV-2 co-infected women during antiretroviral therapy (ART) is associated with an increase in HIV tissue reservoirs and potentially promotes HIV evolution.
    J Virol. 2020 Oct 7. pii: JVI.01606-20. doi: 10.1128/JVI.01606.
    PubMed     Abstract available

  32. BAGRI P, Ghasemi R, McGrath JJC, Thayaparan D, et al
    Estradiol enhances anti-viral CD4(+) tissue-resident memory T cell responses following mucosal herpes simplex virus 2 vaccination through an IL-17-mediated pathway.
    J Virol. 2020 Oct 7. pii: JVI.01206-20. doi: 10.1128/JVI.01206.
    PubMed     Abstract available

    September 2020
  33. PIIRSOO A, Kala M, Sankovski E, Ustav M, et al
    Uncovering the Role of the E1 Protein in Different Stages of Human Papillomavirus 18 Genome Replication.
    J Virol. 2020;94.
    PubMed     Abstract available

  34. ZHENG Y, Jonsson J, Hao C, Shoja Chaghervand S, et al
    Heterogeneous Nuclear Ribonucleoprotein A1 (hnRNP A1) and hnRNP A2 Inhibit Splicing to Human Papillomavirus 16 Splice Site SA409 through a UAG-Containing Sequence in the E7 Coding Region.
    J Virol. 2020;94.
    PubMed     Abstract available

  35. JOSE L, DeSmet M, Androphy EJ
    Pyk2 Regulates Human Papillomavirus Replication by Tyrosine Phosphorylation of the E2 Protein.
    J Virol. 2020;94.
    PubMed     Abstract available

  36. GODI A, Boampong D, Elegunde B, Panwar K, et al
    Comprehensive Assessment of the Antigenic Impact of Human Papillomavirus Lineage Variation on Recognition by Neutralizing Monoclonal Antibodies Raised Against Lineage A Major Capsid Proteins of Vaccine-Related Genotypes.
    J Virol. 2020 Sep 23. pii: JVI.01236-20. doi: 10.1128/JVI.01236.
    PubMed     Abstract available

    August 2020
  37. SHIBAZAKI M, Kato A, Takeshima K, Ito J, et al
    Phosphoregulation of a Conserved Herpesvirus Tegument Protein by a Virally Encoded Protein Kinase in Viral Pathogenicity and Potential Linkage between Its Evolution and Viral Phylogeny.
    J Virol. 2020;94.
    PubMed     Abstract available

    July 2020
  38. KROPP KA, Lopez-Munoz AD, Ritter B, Martin R, et al
    Herpes Simplex Virus Type 2 Counteracts Neurite Outgrowth Repulsion During Infection In A Nerve Growth Factor-Dependent Manner.
    J Virol. 2020 Jul 15. pii: JVI.01370-20. doi: 10.1128/JVI.01370.
    PubMed     Abstract available

  39. JOSE L, Androphy EJ, DeSmet M
    Phosphorylation of the Human Papillomavirus E2 Protein at Tyrosine 138 Regulates Episomal Replication.
    J Virol. 2020;94.
    PubMed     Abstract available

    June 2020
  40. SCAGNOLARI C, Cannella F, Pierangeli A, Mellinger Pilgrim R, et al
    Insights into the Role of Innate Immunity in Cervicovaginal Papillomavirus Infection from Studies Using Gene-Deficient Mice.
    J Virol. 2020;94.
    PubMed     Abstract available

  41. SHARMA S, Munger K
    KDM6A-Mediated Expression of the Long Noncoding RNA DINO Causes TP53 Tumor Suppressor Stabilization in Human Papillomavirus 16 E7-Expressing Cells.
    J Virol. 2020;94.
    PubMed     Abstract available

    May 2020
  42. BANNACH C, Brinkert P, Kuhling L, Greune L, et al
    Epidermal Growth Factor Receptor and Abl2 Kinase Regulate Distinct Steps of Human Papillomavirus 16 Endocytosis.
    J Virol. 2020;94.
    PubMed     Abstract available

  43. MORI S, Takeuchi T, Ishii Y, Kukimoto I, et al
    The Transcriptional Cofactor VGLL1 Drives Transcription of Human Papillomavirus Early Genes via TEAD1.
    J Virol. 2020;94.
    PubMed     Abstract available

    March 2020
  44. BOON SS, Xia C, Lim JY, Chen Z, et al
    Human Papillomavirus 58 E7 T20I/G63S Variant Isolated from an East Asian Population Possesses High Oncogenicity.
    J Virol. 2020;94.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Sexually Transmitted Diseases is free of charge.